Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
| dc.contributor.author | Camprubí, Daniel | |
| dc.contributor.author | Almuedo Riera, Alex | |
| dc.contributor.author | Martí Soler, Helena | |
| dc.contributor.author | Soriano Viladomiu, Alex | |
| dc.contributor.author | Hurtado, Juan Carlos | |
| dc.contributor.author | Subirà, Carme | |
| dc.contributor.author | Grau Pujol, Berta | |
| dc.contributor.author | Krolewiecki, Alejandro J. | |
| dc.contributor.author | Muñoz Gutiérrez, José | |
| dc.date.accessioned | 2021-04-28T09:48:24Z | |
| dc.date.available | 2021-04-28T09:48:24Z | |
| dc.date.issued | 2020-11-11 | |
| dc.date.updated | 2021-04-28T09:48:24Z | |
| dc.description.abstract | Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2. | |
| dc.format.extent | 6 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 710488 | |
| dc.identifier.issn | 1932-6203 | |
| dc.identifier.pmid | 33175880 | |
| dc.identifier.uri | https://hdl.handle.net/2445/176832 | |
| dc.language.iso | eng | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0242184 | |
| dc.relation.ispartof | PLoS One, 2020, vol. 15, num. 11, p. e0242184 | |
| dc.relation.uri | https://doi.org/10.1371/journal.pone.0242184 | |
| dc.rights | cc-by (c) Camprubí, Daniel et al., 2020 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | |
| dc.source | Articles publicats en revistes (Medicina) | |
| dc.subject.classification | COVID-19 | |
| dc.subject.classification | Farmacologia | |
| dc.subject.other | COVID-19 | |
| dc.subject.other | Pharmacology | |
| dc.title | Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1